Introduction Erectile dysfunction (ED) is often portrayed as an inevitable part of aging, a silent yet pervasive condition that robs men of confidence and intimacy. However, the story is far more complex. ED is not merely a urological inconvenience; it is a sentinel marker of vascular health, psychological well-being, and overall quality of life. In […]

Introduction Erectile dysfunction (ED) following prostate cancer treatment remains one of the most distressing complications for patients and their partners. For men undergoing definitive radiotherapy, whether external beam radiotherapy (EBRT) or brachytherapy, sexual function often deteriorates within months to years of treatment. Reported rates of moderate to severe ED range from 40% to 70% at […]

Introduction: More Than Just a Molecule of Relaxation Cyclic guanosine monophosphate (cGMP) has long been known as a second messenger critical to vascular smooth muscle relaxation, a discovery that ultimately revolutionized the management of erectile dysfunction through the development of sildenafil. Yet the reach of this humble nucleotide extends far beyond facilitating vasodilation. It plays […]

Introduction For decades, Alzheimer’s disease (AD) has stood as one of the most formidable challenges in neurology, robbing millions of their memory, independence, and dignity. Despite decades of research, therapeutic breakthroughs remain sparse, with most approved agents offering only symptomatic relief. Disease-modifying treatments, though eagerly anticipated, continue to disappoint in large-scale trials. Against this backdrop, […]

Intrauterine growth restriction (IUGR) remains one of the most vexing problems in modern obstetrics. Affecting roughly 5–7% of pregnancies, it is not simply a matter of having a “small baby.” Rather, it represents a pathophysiological failure in placental or fetal growth mechanisms, with consequences ranging from preterm birth and neonatal mortality to lifelong metabolic and […]

For more than two decades, sildenafil citrate has been celebrated as the little blue pill that transformed the treatment of erectile dysfunction. Its mechanism—blocking phosphodiesterase type 5 (PDE5) to enhance nitric oxide–cGMP signaling—has been widely studied in vascular and smooth muscle physiology. Yet recent research suggests that sildenafil’s story extends far beyond the bedroom. Intriguingly, […]

The management of intrauterine growth restriction (IUGR) remains one of the most pressing challenges in obstetrics. Defined as the failure of a fetus to achieve its genetically determined growth potential, IUGR is a condition that not only complicates pregnancies but also predisposes infants to perinatal morbidity, mortality, and long-term health consequences. For decades, the only […]

Erectile dysfunction (ED) has evolved from a taboo subject whispered behind closed doors to a mainstream medical concern openly discussed in both clinics and commercials. Defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance, ED is now recognized not only as a quality-of-life issue but also as a marker […]

Sexual dysfunction (SD) is a frequently underestimated complication of multiple sclerosis (MS), yet it affects nearly two-thirds of patients across their disease trajectory. Its impact is not confined to the bedroom; it extends into domains of mood, self-esteem, relationships, and overall quality of life. Importantly, SD is not a uniform entity. It encompasses primary neurological […]

Erectile dysfunction (ED) has long been managed with a one-size-fits-all mentality, dominated by the use of phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil. While these agents revolutionized the field by providing a safe, effective, and convenient oral therapy, a growing body of evidence suggests that monotherapy often leaves many patients dissatisfied. Clinical realities—ranging from […]